The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The average estimate of 17 analysts surveyed by Zacks Investment Research was for earnings of $3.80 per share.

Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market trading Thursday. Shares of Elevance gained more than 4% to $408 a share before the bell.

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting."

Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer worked to overcome rising medical expenses.

Elevance Health Inc.’s stock jumped 5% in premarket trade Thursday and boosted other health insurance stocks, after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns after a big miss in the third quarter.

Elevance executives talked about the cost trend environment for employer health plans Thursday, during a conference call with securities analysts. The Indianapolis-based health insurer and health ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target

Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,

Elevance Health's board has raised the health insurer and healthcare-services provider's quarterly dividend by 4.9%, to $1.71 from $1.63. The new payout, equal to $6.84 a year, represents an annual yield of about 1.75%, based on Wednesday's closing price of $390.73, up from 1.67%.

Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.

In a call with investors, CEO Gail Boudreaux didn’t directly address the killing of UnitedHealthcare’s top executive but spent more time than usual arguing Elevance is working to improve healthcare.